Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special

Norihiko Goto1, Yoshihiro Tominaga, Susumu Matsuoka

  • 1Nagoya Daini Red Cross Hospital, 2-9 Myouken-cho, Showa-ku, Nagoya 466-8650, Japan. ngoto@nagoya2.jrc.or.jp

Insights

Secondary hyperparathyroidism (2° HPT) can cause dilated cardiomyopathy (DCM). Parathyroidectomy (PTx) significantly improved left ventricular function in dialysis patients with DCM due to 2° HPT.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Dilated cardiomyopathy (DCM) secondary to hyperparathyroidism (2° HPT) is not well-characterized.
  • The impact of 2° HPT on cardiac function in dialysis patients requires further investigation.

Purpose of the Study:

  • To determine the morbidity of DCM caused by 2° HPT.
  • To evaluate the efficacy of parathyroidectomy (PTx) in improving cardiac function in dialysis patients with advanced 2° HPT.

Main Methods:

  • Prospective analysis of 237 dialysis patients undergoing PTx.
  • Cardiac assessment before and 6 months after PTx in 10 patients with DCM (4% of cohort).
  • Evaluation included echocardiography and clinical assessment of left ventricular (LV) function.

Main Results:

  • Significant improvement in LV ejection fraction (LVEF) from 31.0% to 56.8% (P = 0.0003) six months post-PTx.
  • Reduction in LV end-diastolic dimension (LVDd) from 59.8 mm to 46.3 mm (P = 0.0014).
  • Improvement in DCM symptoms and dialysis-related hypotension observed after PTx.

Conclusions:

  • Advanced 2° HPT negatively impacts LV function, leading to DCM.
  • PTx effectively reverses LV dysfunction in dialysis patients with DCM secondary to 2° HPT.
  • Prompt PTx is recommended for patients with DCM caused by 2° HPT.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...